The Michigan State University College of Osteopathic Medicine has achieved an important milestone, becoming the first osteopathic medical school to be included in the prestigious National Institutes of Health Medical Scientist Training Program, or MSTP.

This award officially recognizes MSU’s D.O.-Ph.D. Physician-Scientist Training Program as one of the top dual-degree programs in the U.S., elevating its influence in the biomedical research community. The MSTP is one of the most competitive medical education programs and provides funding and support for students pursuing dual medical and research degrees.  

“Osteopathic medicine is a cornerstone of Michigan State University’s commitment to advancing health and healing in Michigan and beyond,” said MSU President Kevin M. Guskiewicz, Ph.D. “The inclusion of our D.O.-Ph.D. students in the NIH Medical Scientist Training Program reflects not only the excellence of their dual training, but also MSU’s leadership in reimagining the future of medical education and biomedical discovery. This achievement underscores the national value of osteopathic medicine — and MSU’s role in shaping it.”

Scientific research provides doctors with the knowledge and solutions needed to help prevent disease, as well as diagnose and treat patient illness and injuries. The D.O.-Ph.D. program is for students who are interested in practicing osteopathic medicine and conducting research.